arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ROCKWELL MEDICAL, INC.

RMTI
$8.81 0.00 (-0.06%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

ROCKWELL MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $34.9M
Dividend Yield
Revenue Growth 10.6%
Op. Margin -6.0%
ROIC -2.0%
FCF / Share $0.53
Trailing P/E
Price / Book 1.0x
FCF Yield 6.0%
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Sep 22, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.78M
↑ +10.6%
Net Income Profit after all expenses
$-1.60M
↓ -5.9%
Operating Margin Operating profit as % of sales
-6.0%
↑ +30.1% 18th
FCF / Share Free cash flow per share
$0.53
↑ +12502.4%
Long-Term Debt Long-term obligations
$7.24M
↓ -11.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
20
Returns
31
Financial Health
52
Cash Quality
27

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters